Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
Research Site, Irvine, California Research Site, Palo Alto, California Research Site, Santa Monica, California Research Site, Chicago, Illinois Research Site, Boston, Massachusetts Research Site, St Louis, Missouri Research Site, Omaha, Nebraska Research Site, Cleveland, Ohio Research Site, Pittsburgh, Pennsylvania Research Site, Houston, Texas Research Site, Seattle, Washington Canada
Research Site, Edmonton, Alberta Research Site, Halifax, Nova Scotia Research Site, Montreal, Quebec Research Site, Sherbrooke, Quebec